Arecor Therapeutics PLC (GB:AREC) has released an update.
Arecor Therapeutics PLC, a biopharmaceutical company specializing in enhancing therapeutic products, is set to announce its year-end financial results for 2023 on May 7, 2024. The CEO and Chief Business Officer will conduct an in-person briefing and a live webcast with a Q&A for analysts. The company is known for its proprietary Arestat™ technology platform and its internal portfolio of products, particularly in diabetes care.
For further insights into GB:AREC stock, check out TipRanks’ Stock Analysis page.
